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ABSTRACT: The coronavirus disease 2019 (COVID-19) has
penetrated every populated patch of the globe and sows
destruction in our daily life. Reliable and sensitive virus sensing
systems are therefore of vital importance for timely infection
detection and transmission prevention. Here we present a
thermoplasmonic-assisted dual-mode transducing (TP-DMT)
concept, where an amplification-free-based direct viral RNA
detection and an amplification-based cyclic fluorescence probe
cleavage (CFPC) detection collaborated to provide a sensitive
and self-validating plasmonic nanoplatform for quantifying
trace amounts of SARS-CoV-2 within 30 min. In the CFPC
detection, endonuclease IV recognized the synthetic abasic site
and cleaved the fluorescent probes in the hybridized duplex.
The nanoscale thermoplasmonic heating dehybridized the shortened fluorescent probes and facilitated the cyclical binding−
cleavage−dissociation (BCD) process, which could deliver a highly sensitive amplification-based response. This TP-DMT
approach was successfully validated by testing clinical COVID-19 patient samples, which indicated its potential applications in
fast clinical infection screening and real-time environmental monitoring.
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O ver the past year, the coronavirus disease 2019(COVID-19) pandemic caused by the severe acuterespiratory syndrome coronavirus 2 (SARS-CoV-2)
has penetrated every populated patch of the globe and sows
destruction in daily life all around the world.1 This ongoing
pandemic has engendered more than 113 million cases of
infection and 2.5 million fatalities globally (as of February 27,
2021).2 Before effective vaccines are released to the general
public, wide-scale testing and social distancing are still the
most effective way to mitigate the spreading of SARS-CoV-2.3,4
The wide-scale viral testing should not only encompass the
surveillance test of suspected patients and the general public
but also involve monitoring of the daily environment.5 In the
infection screening and surveillance test, a highly sensitive
diagnostic system could provide reliable results and triage
people suspected of SARS-CoV-2.6 Meanwhile, a sensitive
biosensing system can also be used for environmental
monitoring with auxiliary modules for on-site sample
collection, enrichment, and detection, so as to provide timely
alerting as to the presence of the virus.7−9 Currently,
polymerase chain reaction (PCR) is able to detect extremely
low amount of viruses by means of nucleic acid (NA)
amplification and has been utilized in clinical COVID-19
diagnosis as a “gold standard”.10,11 Generally, the PCR
technology requires sample pretreatments and usually
inflexible desktop detection facilities; thus it has a limited
role in real-time and point-of-care (POC) detection.11,12
Several biosensing systems for SARS-CoV-2 POC detection
have been developed. According to the sensing targets, these
biosensing approaches can be divided into two categories: viral
NA-based detection and the viral protein-based detection (e.g.,
the spike protein).13−16 Specific protein-based immunodetec-
tion is the most straightforward way to identify the presence of
pathogens, and this concept can be combined with different
biosensing platforms, including the field-effect transistor
(FET) biosensor,17 plasmonic biosensors,18,19 and lateral
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flow assay (LFA).20,21 By contrast, viral NA-based biosensors
detect a particular viral NA sequence, which in principle have
better specificity.22 For instance, the SHERLOCK (specific
high-sensitivity enzymatic reporter unlocking) method and the
DETECTR (DNA endonuclease-targeted CRISPR trans
reporter) method based on CRISPR-Cas12 or CRISPR-
Cas13 have been developed for detecting the SARS-CoV-2
virus.23−26 The fluorophores released by the Cas-proteins
could be excited, and the fluorescent emission was used for
quantifying the amount of viral sequences.27 The NA
detection, which incorporates this amplification process to
enhance the detection signal, has grown into a mainstream
pathogen detection approach with both superior sensitivity and
specificity. However, limited by the fluorescence readout
method, CRISPR-based detection generally requires the
preamplification of target NA or combining multiple crRNAs
targeting different viral RNA regions.26,27 Biosensors that have
higher sensitivity than the direct fluorescence or colorimetric
readout scheme could provide fast-response results and
capability for POC detection.28 Among them, plasmonics,
including the localized surface plasmon resonance (LSPR) and
surface plasmon polariton (SPP), have become indispensable
tools for label-free detection of molecules and quantification of
the binding kinetics.29−32 Therefore, combining the amplifica-
tion process and plasmonic detection could further increase
the overall performance of biosensing. Meanwhile, the energy
losses of plasmonics and the associated heat generation at the
nanoscale, known as the plasmonic photothermal (PPT) effect
or thermoplasmonics, could benefit a broad range of research
and innovation topics, including photothermal-assisted plas-
monic sensing (PTAPS).33−35 Our recent study proved that
the plasmonic biosensor utilizing the dual functions of photon-
stimulated electromagnetic field and the dissipated local
photothermal heat was able to facilitate the specific NA
hybridization and achieve a sensitive direct detection of the
nonamplified NA sequences of SARS-CoV-2.35 Compared
with traditional macroscopic heating approaches, the localized
thermoplasmonic heating can significantly enhance the
reactivity of biomolecules in the vicinity of the LSPR sensing
surface by establishing a two-dimensional nanoscale heating
zone, while the bulk solution is kept at a lower temperature
(room temperature) to suppress the reactivity of biological
components.36 These findings suggested that the thermoplas-
monic and near-field heating also have potential to regulate the
biocatalytic behaviors of site-specific nucleases, thereby
achieving in situ amplification-based detection on a nano-
photonic chip and further improving the sensitivity of the
plasmonic biosensor.35
In this work, we further extend the utility of the PTAPS
biosensing system based on our recently published work35 and
introduce a thermoplasmonic-assisted dual-mode transducing
(TP-DMT) concept, which is able to provide self-validating
biosensing readouts for quantifying the viral NA sequence
(Figure 1). The gold nanoisland (AuNI) on the sensor chips
was employed as a multifunctional medium with the roles of
nanoabsorber, nanoheater, and nanotransducer. The thermo-
plasmonic heating is able to regulate the local biological
reactions including the NA sequence hybridization, the
endonuclease cleavage, and the cyclic binding−cleavage−
dissociation (BCD) reaction, while the direct LSPR sensing
with the AuNI nanotransducer is able to monitor the nanoscale
reactions and provide dual sensitive responses for SARS-CoV-2
quantification. The first amplification-free biosensing readout is
based on the hybridization between the viral target sequences
and the functionalized thiol-DNA receptors. With the aid of
thermoplasmonics, the two-dimensional AuNI array can
provide a suitable local heating condition for the specific
hybridization and monitor the real-time molecular binding
within the LSPR near-field. The LSPR transducing signal is
correlated with the captured NA sequence amount and can be
used to evaluate the virus concentration. The limit of detection
(LOD) of the direct detection can reach 0.1 ± 0.04 pM. The
second LSPR biosensing readout is derived from the cyclic
fluorescence probe cleavage (CFPC). Endonuclease IV, a site-
specific nuclease, is utilized to cleave the synthetic apurinic/
apyrimidinic (AP) site when the fluorescent DNA probes
hybridize with the target sequences, splitting the long DNA
probes into two short strands. Within the local thermoplas-
monic field, the two short strands which contain 5′-
fluorophore and 3′-quencher termini can dissociate from the
target sequence and emit the “switch-on” fluorescent signal.
These cyclically released fluorescent probes can stimulate
transient and cumulative LSPR responses, thereby providing
highly sensitive quantification results with an improved LOD
of 0.275 ± 0.051 fM.
RESULTS AND DISCUSSION
Near-Field Photothermal Effect for Plasmonics Bio-
sensing. The thermoplasmonic effects, which provided the
Figure 1. Schematic of TP-DMT viral sensing workflow. The AuNI
plasmonic chip functionalized with the complementary DNA
receptor can specifically hybridize with the target viral sequence
and provide the direct phase detection signal for the first
quantification analysis. Subsequently, the AP-site-modified fluo-
rescent probe and Endo-IV are introduced. The Endo-IV is capable
of cleaving the AP site after the fluorescent probe hybridizes with
the viral sequence. With the assistance of the local PPT heating,
the shortened fluorescent probe thermally dehybridizes from the
target viral sequence and stimulates the LSPR response as a
nonquenched gain medium, thereby providing a highly sensitive
secondary CFPC detection signal.
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desired temperature for NA hybridization, Endo-IV cleavage,
and cyclic fluorescent probe release, were experimentally
characterized by measuring the thermo-induced variation of
the refractive index.37 The two-dimensional densely distributed
nanoabsorbers (AuNI) were initially optimized to have the
peak absorption at 532 nm with a normal incident angle.35,38
When irradiated by the homogenized 532 nm laser
(Supplementary Figure S1a), the hot electron−hole pairs
were photoexcited within the AuNI nanoabsorbers. Within a
time period on the order of nanoseconds, the photoexcited
plasmon quickly transferred to the metallic lattice and
eventually released the thermal energy to the surrounding
water medium through electron−phonon collisions (Figure
2A).39 This thermal dissipation process was responsible for a
local temperature elevation and a thermally induced variation
of the refractive index in the vicinity of the AuNIs.40 In the
thermoplasmonic and biosensing tests, the homogenized
square laser spot fully covered the center region of the
Figure 2. Thermoplasmonic characterization and local temperature calibration. (A) Schematic illustration of the local thermoplasmonics of
AuNIs. The 532 nm laser was matched with the peak absorption of the optimized AuNI chip, which led to a high photothermal efficiency.
(B) Real-time differential phase responses stimulated by increased irradiation power. The laser power increased step-by-step from 13.44 W/
cm2 to 94.56 W/cm2 with 15 complete laser on/off irradiation cycles. (C) Thermoplasmonics of AuNIs led to the interferometric spectra
shift, and each fringe with a different phase condition corresponded to a specific local temperature elevation. (D) Correlation curve of
photothermal heating and phase change obtained through three repeated temperature calibrations. The solid black curve represents the
Δphase−ΔT correlation of mean values, and the red-shaded area represents the standard deviation (±δ) of the corresponding temperature
or phase response.
Figure 3. Photothermal hybridization and dehybridization with in situ LSPR phase monitoring. (A) The complementary probe hybridized to
a specific position of the NA target (inset), thereby triggering a real-time LSPR phase change. (B) The plasmonic sensor chip loaded with the
hybridized NA sequence was treated by a series of photothermal laser on/off cycles with gradually increased power, and the dehybridization
(NA dissociation) at different temperatures was investigated. (C) Absolute phase responses caused by NA dehybridization at different
temperatures. When the AuNI thermoplasmonic field generated local temperatures higher than 42.5 °C, part of the hybridized
complementary strands underwent thermal dissociation (inset).
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microfluidic channel and the transducing region as shown in
Supplementary Figure S1b. We believed that the square laser
beam (4 mm2) with an even power distribution can provide a
uniform thermoplasmonic irradiation in the center sensing
region (0.2 mm2). By gradually increasing the irradiation
power, a fast and stable in situ temperature adjustment could
be achieved (Figure 2B). Simultaneously, we exploited the
total internal reflection (TIR) light and LSPR to transduce the
spectral phase shift and quantify the variation of the refractive
index and local temperature.32 According to the interfero-
metric spectra in Figure 2C, the PPT heating thermally
induced a decrease of the local refractive index of the ambient
solution and therefore transformed the resonance wavelength
shift to a shorter wavelength region. The interference fringe
with the smallest amplitude shifted from approximately 585
nm at room temperature (blue spectrum) to 580 nm (red
spectrum) after thermoplasmonic heating. By using the
windowed Fourier transform (WFT) method as described in
Supplementary Figure S1c−e and our previous works, the
differential phase response was extracted and used for a
quantitative real-time retrieval of the local temperature.41,42
The detailed temperature characterization and plasmonic
heating calibration can be found in Supplementary Figure S2
and our recent work on the PTAPS.35 The retrieved
relationship between the LSPR phase response (Δphase) and
elevated temperature (ΔT) (Figure 2D) was used to estimate
the nanoscale temperature around the AuNIs, which regulated
the local reactions including the sequence hybridization,
endonuclease cleavage, and cyclic BCD reaction.
At a temperature below the melting threshold (Tm), two
complementary NA strands can form a thermodynamically
favored double-helix (duplex) structure by establishing the
noncovalent and sequence-specific base-pair interaction.43 This
perfect bonding, known as the NA hybridization, is the
molecular basis for many biological processes and NA
analytical biotechnologies.44 In our first-step hybridization
test as shown in Figure 3A, the LSPR differential
interferometric phase sensing system probed the on-chip
hybridization of two complementary sequences (i.e., the
synthetic target viral sequence VTS-nsp13 and its comple-
mentary viral receptor specified in Supplementary Table S1).
Specifically, the thiolate DNA receptors were covalently
immobilized onto the AuNI photonic chips through forming
Au−S bonds. When the fully matched sequences reached the
functionalized biosensing surface, the DNA receptors were able
to capture and hybridize with these target sequences as shown
in the inset of Figure 3A. This binding reaction changed the
local refractive index surrounding the AuNIs and was directly
sensed by the LSPR near-field, thereby producing a fast and
real-time phase response.42 In order to further understand the
thermodynamics of the immobilized nucleic acids, we used the
PTAPS platform to study the hybridization and dehybridiza-
tion behaviors. The far-field laser excitation was able to control
the near-field thermoplasmonic heating on the AuNI sensor
surface to reach the desired temperature, therefore optimizing
the hybridization condition for a specific sequence.45
Generally, higher temperature can increase the free diffusion
of single-stranded NA sequences and make the hybridization
Figure 4. In situ transducing amplification with cyclic Endo-IV reaction. (A) Schematic illustration of the signal amplification cycle with (i)
fluorescent probe binding, (ii) AP site cleavage by Endo-IV, (iii) photothermal release of the cleaved short oligos, and (iv) fluorophore
accumulation with cyclic cleavage and thermal release reaction. (B) Real-time sensorgram of the cyclic amplification, with a typical laser-off
background and an amplified phase response under PTAPS. (C) Transient phase response signal obtained by subtracting the accumulated
change. The green scattered dots (1−500 s) represent the background signal without laser irradiation, and the red scattered dots (500−1200
s) represent the transient phase responses stimulated by the near-field cyclic released fluorophores. (D) Phase response distribution of the
background and transient signals. (E) Direct detection of gain molecules (rhodamine 6G) to investigate the amplification efficiency of gain-
assisted plasmonic detection.
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thermodynamically favorable, thereby improving hybridization
kinetics.46 However, temperatures approaching the melting
threshold cause the dehybridization of double-stranded NA
sequences. As shown in Figure 3B, we performed a series of in
situ dehybridization tests on the DNA duplexes by gradually
increased PPT heating. The thermoplasmonic-induced local
temperature gradually increased from 37.9 °C to 45.6 °C. After
each heating cycle, the irradiation laser was switched off, and
the local temperature quickly reduced to a typical room
temperature at 25 °C. Under this laser-off condition, the real-
time phase response with a negative value was recorded and
used to determine whether the PPT-induced dehybridization
occurred. As shown in Figure 3C, when the thermoplasmonic
temperature was below 41.6 °C, the absolute values of the
dehybridization responses were weak, which indicated that the
NA duplexes maintained the double-stranded state. However,
in a PPT near-field with the temperature higher than 42.5 °C, a
negative LSPR phase signal appeared (Figure 3B), which
indicated that part of the NA duplexes had dehybridized by the
AuNI thermoplasmonic field. This dehybridization process was
substantial at temperatures higher than 42.5 °C (Figure 3C)
for this target viral sequence, showing that higher temperatures
were not favorable for effective in situ detection of the selected
viral NA target.
Amplification-Based CFPC Biosensing with Endo-IV.
Direct hybridization detection, representing the amplification-
free sensing approach, is able to probe samples quickly with
high virus content.7 However, when there is only a trace
amount of virus in the sample, the detection becomes
challenging. Therefore, improving the sensitivity plays a
significant role for sensor development. Here, we utilized
Endo-IV and the fluorescent probe (22nt) possessing a
synthetic AP site for the cyclic gain-assisted amplification
and in situ secondary CFPC transducing. Endo-IV plays a
crucial role in repairing damaged DNA-containing abasic
sites.47 It specifically recognizes and cleaves the AP site within
a DNA duplex by generating a hydroxyl group at the 3′-
terminus. In the CFPC detection, 50 μL of freshly prepared
reaction solution containing 1 unit of Endo-IV and 1 μM
fluorescent DNA probes was applied onto the biosensor
surface loaded with the captured target sequences. The PPT
local heating provided a suitable nanoscale temperature (T =
41.3 ± 0.2 °C, with Δphase = 1.85 rad) for both DNA
hybridization and enzyme cleavage. On the AuNI surface, the
synthesized fluorescent probes first hybridized with the
captured sequences in the section that was still single-stranded
(Figure 4A, i,ii). The melting temperature Tm of the
fluorescent probe was determined to be 54 °C with nearest-
neighbor methods (Supplementary Table S1). Then, Endo-IV
recognized the AP site in the middle of the probe and cleaved
the probe into two short pieces (Figure 4A, ii,iii), which
contained an ATTO532 fluorophore and a BHQ1 quencher,
respectively. After the cleavage, the two short oligonucleotides
possessed much lower melting temperatures at 34 and 30 °C,
respectively (Supplementary Table S1). Since the PPT-
induced local temperature was evidently higher than their Tm
thresholds, the two short oligonucleotides dissociated from the
target sequence and departed from the single-stranded viral
sequence, leaving it available for the next cyclic BCD reaction
(Figure 4A, iii). The cleavage performance of the Endo-IV on
single- and double-stranded sequences with AP sites was
further verified with real-time PCR characterization (Supple-
mentary Figure S3). It was found that the Endo-IV was
specifically reactive on the double-stranded sequences
possessing the synthetic AP sites, while exhibiting an extremely
low cleavage rate on the single-stranded probes (control in
Supplementary Figure S3). It is worth noting that the
thermoplasmonic field by the two-dimensional distributed
AuNI array has a small penetration depth into the dielectric
media. Therefore, the temperature of the bulk solution is not
impacted by the localized heating, and the restriction
endonuclease away from the surface has limited reactivity,
thereby reducing nonspecific enzymatic reactions. In the
CFPC test, the released fluorophores were simultaneously
excited by the 532 nm laser and emitted photons of a low
energy (Supplementary Figure S4). Before diffusing into the
bulk solution, the released fluorophores were in the vicinity of
the AuNI biosensing surface (about 14.9 nm based on the B-
DNA structural form). Since the randomly distributed AuNI
nanophotonic chip has a broad absorbance superimposing over
both the excitation and emission peak of the ATTO532
fluorophore, this distance (<15 nm) could facilitate the direct
energy transfer between the fluorophore and AuNIs, therefore
stimulating a transient LSPR phase response through the near-
field interaction as shown in the real-time sensorgram (Figure
4B and C).48 In comparison with the background phase
response (without laser excitation) in the first 500 s of the
reaction, the near-field interaction (500 to 1200 s) between the
released fluorophores (gain molecules) and LSPR AuNIs
produced transient phase jumps with high amplitudes.
Different from the molecular binding, the instantaneous
phase responses caused by this energy transfer and gain
medium stimulation demonstrated a wider phase distribution
(Figure 4D). As a signal distinct from the background LSPR
phase response, this transient phase jump provided qualitative
proof to verify the existence of the target sequence.
This cyclic BCD process proceeded continuously on the
AuNI biosensor surface under the cooperation of Endo-IV and
local thermoplasmonic heating. Subsequently, the fluorescent
DNA probes diffused into the bulk solution, and the overall
fluorescence intensity gradually increased over time (Figure
4B). The accumulated fluorescent irradiation was able to
continuously stimulate the LSPR response as an optically
active gain medium. According to the literature, the gain-
assisted amplification, which is known as the surface plasmon
amplification biosensor (SPAB), could amplify the LSPR phase
shifting in the TIR light and be used for highly sensitive
quantification (Figure 4B).49 As a control experiment, we
further verified the gain-enhanced detection by using laser-
assisted detection of rhodamine 6G (R6G) fluorophores in the
liquid. As shown in Figure 4E, laser excitation of the
photoactive medium (i.e., R6G) significantly amplified the
LSPR phase detection response compared to that without laser
irradiation. Since the ATTO532 molecules have similar
emission properties to R6G (Supplementary Figure S4), this
set of control experiments proved that the cumulated
fluorescent probes in the liquid effectively provided sensitive
and reliable gain-assisted SPAB biosensing results. The CFPC
reaction and gain-assisted amplification could only happen
when the fluorescent probe, Endo-IV, and photothermal field
coexisted (Supplementary Figure S5). Moreover, under the
same temperature (corresponding to a constant cleavage rate
by the Endo-IV) and time duration, the accumulation rate of
the released fluorescent DNA probe was proportional to the
number of target NA sequences on the AuNI biosensor chip.27
Therefore, the differential CFPC phase response can be used
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for the quantitative measurement of the viral NA concen-
tration.
Quantitative Analysis with the Dual-Mode Biosen-
sors. The TP-DMT sensing concept, which combined the
direct hybridization and CFPC detections, was first validated
with the synthetic viral sequence of SARS-CoV-2. According to
the reference SARS-CoV-2 full genomic sequence
(NC_045512.2) in GenBank, we selected the viral target
sequence in the helicase/nonstructural protein 13 (nsp13)
gene region as shown in Figure 5A. This viral target sequence
(VTS-nsp13) with a length of 65nt has good representative-
ness and specificity compared with the corresponding location
of six other human coronaviruses (Supplementary Table S2).
Based on this target VTS-nsp13 sequence, we further designed
the complementary DNA receptor for direct detection of the
virus sequence, as well as the AP-site-modified fluorescent
probe containing a 5′-ATTO532 head and a 3′-BHQ1
quencher terminus (Figure 5A) for CFPC reaction. We
utilized conventional PCR to detect both the standard
SARS-CoV-2 sequences and the selected 65nt VTS-nsp13
sequences, so as to further verify the quality and performance
of these synthetic probes and receptors (Supplementary
Figures S6 and S7). With the thiol modification, the AuNI
biosensing chips were directly functionalized with the viral
receptor through Au−S covalent bonding, and the detailed
optimization of surface functionalization was discussed in our
recent PTAPS work.35 The functionalized microfluidic AuNI
biosensing chip was initially used for the direct viral target
sequence quantification. The real-time direct detections of
VTS-nsp13 with a concentration range from 0.1 pM to 10 nM
Figure 5. Genomic design and selection of the NA probe/receptor used for TP-DMT detection of SARS-CoV-2, and the analytical sensing
performance in the direct and CFPC detections of the viral sequence. (A) Selected NA probe/receptor, viral target sequence, and their
relative positions in SARS-CoV-2 (NC_045512.2, GenbBank). (B) Real-time sensorgrams of the target sequence direct detection, with a
series of concentrations from 0.1 pM to 10 nM. (C) Calibration curve of the direct detection responses versus the target sequence
concentrations using the PTAPS. (D) Real-time sensorgrams of the CFPC detection by using the Endo-IV and fluorescent probe, with a
series of concentrations from 0.01 pM to 10 nM. (E) Comparison of the first-step direct detection (with 800 s reaction time) and secondary
CFPC detection (with 500 s reaction time). (F) Mapping the detection responses of the CFPC detection as a function of the reaction time
and VTS-nsp13 concentration. The green reference surface is the direct detection responses of different NA concentrations with a constant
800 s reaction time.
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are shown in Figure 5B. Prior to the detection, a baseline was
established. In each detection, the standard VTS-nsp13 sample
was injected into the microfluidic PTAPS detection chamber.
The thermoplasmonic assistant unit constructed a uniform
two-dimensional photothermal field on the surface of the AuNI
sensor, thereby promoting the rapid hybridization between the
VTS-nsp13 and the complementary DNA receptor. After the
direct hybridization stage, we continued to flush the micro-
fluidic AuNI sensor with nuclease-free water to remove
nonspecific binding substances on the surface and acquired
the final differential phase responses. The quantification
regression curve was obtained by calibrating the final phase
responses of the varying VTS-nsp13 sequence concentrations
as shown in Figure 5C. The direct sensing system attained the
saturation and maximum response condition when the
concentration of the VTS-nsp13 sequence reached 100 nM.
Defining the LOD as the sum of blank measurement responses
(i.e., 0.0029 rad) and triple the standard deviation of the
background noises (i.e., 3 × 0.0031 rad), we calculated that the
LOD of the direct viral sequence detection was about 0.1 ±
0.04 pM (Supplementary Figure S8).
After the direct viral sequence detection, we next used the
mixture of Endo-IV and fluorescent probes to perform the
secondary CFPC detection. The fluorescent probes initially
hybridized to the captured VTS-nsp13 sequences by forming a
DNA duplex (Figure 4A, i,ii). Then the Endo-IV recognized
the AP site in the DNA probe and cleaved the fluorescent
probes into two short strands. Simultaneously, the local
thermal field constructed by the homogenized laser beam
dissociated the two short strands and “switched-on” the
fluorescent gain medium to amplify the plasmonic response, as
demonstrated in Figure 4A. As this BCD process can be
circularly performed under the thermoplasmonic effect, we
observed the LSPR phase response continuously increased
(Figure 5D). Different from the hybridization-based direct
detection, this gain-assisted CFPC detection signal continued
to grow in a linear manner over a long period of time. In the
concentration range from 0.01 pM to 10 nM, the LSPR phase
increment was positively correlated with the concentration of
the VTS-nsp13 sequence. We initially set the CFPC reaction
time to 500 s, and the regression fitting of the TP-DMT
detection is given in Figure 5E. It was found that the CFPC
approach reported enhanced phase responses when detecting
the viral sequence with concentrations lower than 30 pM.
Using the same LOD calculation method as described above,
we estimate the LOD of CFPC detection as 0.275 ± 0.051 fM
(Supplementary Figure S9), which was more than 2 orders of
magnitude lower than that of the direct detection approach.
We subsequently analyzed the CFPC detection responses at
different reaction times and further compared them with the
direct LSPR hybridization detection at different concentration
levels (Figure 5F). Thanks to the cyclic BCD reaction and the
Figure 6. TP-DMT biosensing validation with COVID-19 patient samples. Swab samples from eight patient volunteers were tested using
both the direct detection and CFPC detection approaches. (A) Real-time detection of five clinical samples with the direct detection method
(the blue curves) and CFPC detection method (the red curves). All patient samples were diluted 50 times with nuclease-free water. (B)
Comparison of the LSPR phase responses of the two proposed detection methods. (C) Relationship between the RT-PCR cycle threshold
and the responses of the TP-DMT sensor.
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cumulated gain stimulation, the CFPC-based LSPR detection
demonstrated higher sensitivity than the direct detection
approach. Especially when detecting the low-concentration
samples (<0.1 pM), the CFPC-based detection was capable of
providing reliable biosensing results, while the direct detection
could hardly report an accurate phase response for viral
quantification (Figure 5F). The amplification-based CFPC
detection approach outperformed the direct hybridization
(amplification-free) detection in the low concentration range,
which made the CFPC approach more sensitive. The improved
sensitivity of the CFPC detection was at the expense of
extended reaction time and extra reagents. Nevertheless,
compared with other SARS-CoV-2 biosensors (Supplementary
Table S3), the overall biosensing performance of the CFPC
detection is still very competitive for fast and sensitive SARS-
CoV-2 detection. In contrast, the direct detection method
could give quantitative test results when analyzing higher
concentration samples. In practical applications, when the
direct LSPR detection and the CFPC detection both report
positive (or negative) results, self-verification of these dual-
mode readouts is achieved, which delivers a more reliable viral
biosensing result (Supplementary Table S4). If the final
readout of the direct viral hybridization detection provides
negative results or weak positive responses (possibly caused by
spurious hybridization or nonspecific bonding), the secondary
CFPC could further verify whether the sample contains a trace
amount of the viruses. Compared with the conventional PCR
approach, the TP-DMT biosensing system can be faster,
providing two sensitive readouts within 30 min, and the reverse
transcription process can be omitted. Compared with other
electrochemical or optical SARS-CoV-2 biosensors, the TP-
MDT system can implement two interdependent yet different
self-validating tests on the single AuNI chip, thereby achieving
higher accuracy and reliability.
Clinical-Patient-Sample Test with the TP-DMT Bio-
sensor. To further validate our TP-DMT concept, we next
tested clinical swab samples from volunteer patients, including
the COVID-19 positive and negative samples determined by
the standard reverse transcript RT-PCR (Supplementary Table
S5). For each patient sample, we performed the TP-DMT
analysis of direct hybridization detection and CFPC amplified
detection (Figure 6A and Supplementary Figure S10). In the
real-time direct detection of the positive samples (blue curves
in Figure 6A), the viral RNA in the 50-fold diluted patient
sample in situ hybridized with the viral DNA receptors on the
sensor and caused an LSPR phase shift. In the final flushing
stage, the phase alteration caused by the bulk refractive index
change was further eliminated. The final phase responses were
utilized to determine the presence of the SARS-CoV-2 viral
RNA in the samples. The decreased phase signal in the flushing
step in Figure 6A and Supplementary Figure S10 demonstrated
the refractive index changes caused by the testing medium. It is
worth noting that flushing with buffer solution when testing
clinical or environmental samples was important to eliminate
the nonspecific binding events so that the final LSPR detection
response was representative of the specific hybridization of the
target RNA. In the analysis of the positive samples with a
typical viral loading, the direct hybridization detection was
capable of providing reliable viral biosensing results. These
positive signals were consistent with the RT-PCR detection as
given in Table S5. The sample from patient-5 represented a
biospecimen with a relatively low viral load. It was confirmed
positive for COVID-19 with the highly sensitive Xpert Xpress
SARS-CoV-2 RT-PCR assay running on a GeneXpert System
(Cepheid, USA), whereas three other different RT-PCR assays,
namely, Cobas SARS-CoV-2 running on a Cobas 6800 system
(Roche Diagnostics, Mannheim, Germany), QIAstat-Dx
Respiratory 2019-nCoV Panel (Qiagen, Germany), and an
in-house-developed RT-PCR method at the Institute of
Virology, University of Zurich, all reported negative results.
The COVID-19 infection was further verified by testing the
serum antibodies, which reported positive results for both IgG
and IgA, indicating seroconversion. In the LSPR direct
detection of sample-5, only a weak LSPR signal was obtained
after the buffer flushing, which was similar to the signal of the
negative samples (Supplementary Figure S10). The results
demonstrate that the direct detection method was only capable
of processing clinical samples with relatively high virus
concentrations (>104 copies/mL), while low viral load samples
need to be further verified by the CFPC biosensing approach.
In the subsequent CFPC test, the SARS-CoV-2 sequences in
the positive COVID-19 patient samples initiated the
continuous reaction of cleavage and fluorescence enhance-
ment, enabling the LSPR system to report robust phase
responses (red curves in Figure 6A). Especially when testing
sample-5, a positive CFPC phase response was retrieved, thus
confirming the presence of trace virus sequences in the sample.
By directly comparing the dual-mode results of TP-DMT
(Figure 6B), we found that for both positive and negative
samples TP-DMT could provide cross verification and
therefore deliver results with high accuracy. For clinical
samples with low virus content, e.g., positive patient sample-
5, the secondary CFPC detection demonstrated higher
sensitivity. By correlating the TP-DMT LSPR sensing results
with the RT-PCR threshold cycles (Figure 6C), we further
retrieved the quantitative relationship between the dual-mode
sensing results and the viral loading. The regressions further
proved that direct detection and CFPC detection can
effectively perform self-validating dual-mode detection on
viral samples. Between them, the direct detection featured
better linearity, while the CFPC detection demonstrated better
sensitivity.
CONCLUSIONS
In this study, we present the cleavage-amplification-based
plasmonic biosensing approach as an amplification-based
detection to identify the presence of the target SARS-CoV-2
virus. As an amplification restrictase, Endo-IV recognized the
synthetic AP site and cleaved the fluorescent probes in the
hybridized duplex. Within the nanoscale thermoplasmonic
field, the shortened probe which contains a fluorophore
terminus dissociates from the target viral sequence and emits
the “switch-on” fluorescent signal. These cyclically released
fluorescent probes stimulated the LSPR response as a
photoactive gain medium, thereby providing highly sensitive
readouts for quantifying SARS-CoV-2 sequences. Combined
with the thermoplasmonics and direct viral sequence detection,
the concept of TP-DMT was realized and validated. This TP-
DMT concept can achieve rapid and reliable viral sequence
detection at different concentration levels. Especially for the
samples with trace amounts of viruses, this dual-mode
detection method can achieve a lower detection limit and
higher reliability compared to the direct hybridization
approach. Furthermore, we validated our biosensor with
clinical samples from COVID-19 patients. This TP-DMT
biosensing platform with multifunctional nanotechnologies has
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demonstrated valuable merits for rapid, sensitive, and reliable
detection, which has a promising application prospect in real-
time virus detection and early warning of SARS-CoV-2. In the
context of the COVID-19 pandemic and postpandemic era,
this proposed biosensing platform can be a potential tool for
fast clinical infection screening and real-time environmental
monitoring, therefore contributing to public health interven-
tions and restoring normal production and life.
MATERIALS AND METHODS
Materials. All chemicals were purchased from commercial
suppliers and used without further purification. Nuclease-free water
(Sigma-Aldrich) with 50 mM NaCl was used as the general buffer for
dilution of the synthetic viral target sample and patient samples.
SARS-CoV-2 target sequences were designed based on the available
reference genomes (NC_045512) from GISAID. The selected viral
probes and receptors were synthesized and provided by Microsynth
(Balgach, Switzerland). Endo-IV (2 U/μL, EN0591, Thermo-Fisher)
was used in the CFPC detection to recognize and cleave AP sites of
the double-stranded sequences in the reaction buffer (with 50 mM
Tris-acetate, 50 mM NaCl, 50 mM KCl, 1 mM EDTA, 0.05 v/v%
Triton X-100, pH 7.5).
Thermoplasmonic Characterization. The thermoplasmonic-
induced local temperature was characterized through measuring the
thermo-induced variation of the refractive index.35 To calibrate the
LSPR phase responses to the alteration of the thermo-induced
refractive index, we measured the temperature change and phase
response of a water solution in parallel as shown in Supplementary
Figure S2. Subsequently, the 532 nm laser (GML-FN-532 nm-1.5W,
CNI, Changchun) with a homogenized beam (Supplementary Figure
S1a) was applied on the AuNI sensor chip to construct the local
photothermal fields. By adjusting the output power of the laser, the
local temperature of the photon-induced heating could be adjusted.
AuNI Biosensor Fabrication and Surface Functionalization.
The AuNI sensor chips were synthesized through thermal dewetting
of a Au nanofilm (about 5.1 nm) at 550 °C for 3 h.42 Subsequently,
the PDMS microfluidic channels and AuNI sensor chips were bonded
via oxygen plasma. Immobilization of viral thiol-DNA receptors on
AuNI sensors followed our previously reported method.35 The AuNI
sensor surface was functionalized through flowing 100 μL of freshly
prepared viral sequence receptor (10 μM) for 30 min. After flushing
with the buffer, the AuNI chips were then rinsed with 6-mercapto-1-
hexanol (MCH) for 15 min. By thoroughly flushing with the nuclease-
free water, the AuNI sensor chips were ready for the TP-DMT
detections.
Sequence Hybridization and Dehybridization Tests. In the
hybridization tests, 100 μL of target sequence samples was injected
into the microfluidic AuNI detection chamber; afterward, it was
rinsed with a buffer of 50 nM NaCl. The LSPR white-light common-
path interferometric phase detection system transduced the local
sequence hybridization in real time.41 The AuNI chips containing the
hybridized sequence were subsequently used for investigating the in
situ PPT-induced dehybridization. In detail, gradually increased laser
power was applied onto the AuNI chip. When the local
thermoplasmonic temperature was high enough to break the stacking
attraction between the complementary bases, we observed the
corresponding phase responses in the phase sensorgram.
Detection with the TP-DMT Biosensor. The TP-DMT
detection concept included the direct viral sequence detection and
the CFPC detection to provide self-validating viral-sensing results.
The direct viral sequence detection was based on the hybridization
reaction demonstrated above. In addition, the optimized PPT
temperature was applied on the AuNI chip to further enhance the
hybridization kinetics. In CFPC detection, a 50 μL reaction solution
containing a unit of Endo-IV and 1 μM fluorescent DNA probes was
injected into the reaction chamber for the cyclic BCD reaction. The
homogenized laser beam provided thermoplasmonic assistance in this
reaction process: providing an elevated temperature suitable for Endo-
IV to cleave the AP sites in the DNA duplex and making the short
oligo sequences dissociate from the viral target sequences. The
excitation of surface plasmons manifested itself as the phase shift near
the resonance wavelength at approximately 584 nm. By employing the
windowed Fourier transform calculation, the phase change was
extracted from the spectral interferometric patterns and utilized for
quantifying the local refractive index change and molecular bind-
ings.41,42
Patient Clinical Sample Collection and Preparation.
Nasopharyngeal swabs from patients with suspected COVID-19
eluted in universal transport media were collected and analyzed at the
University Hospital Zurich. The RNA samples of the patient samples
were transported to the ETH laboratory for the TP-DMT studies.
Sample RNA of SARS-CoV-2 was analyzed following instructions as
described in the FDA-approved protocol with the Xpert Xpress SARS-
CoV-2 RT-PCR assay running on GeneXpert System (Cepheid,
USA). This RT-PCR assay targeted both (N2 and E) nucleic acids.
The LOD for this assay was 250 copies/mL.
Real-Time RT-PCR Assay to Confirm the Viral Fluorescent
Probe Performance and Monitoring of Endo-IV Activity. To
confirm the viral fluorescent probe performance, a 10 μL reaction
containing 1 μL of SARS-CoV-2 qPCR template standard
(HK212669, ORIGENE) or 1 μL of VTS-nsp13 sequence, 5 μL of
2× TaqMan master mix was used. qPCR primer mix was used at 5
pmol per reaction and viral fluorescent probe was used at 20 pmol per
reaction. Thermal cycling was performed at 95 °C for 20 s and then
45 cycles of 95 °C for 1 s and 60 °C for 20 s by Applied Biosystems
ViiA7 instruments (Applied Biosystems, Switzerland). To monitor
Endo-IV activity, a 10 μL reaction solution that contained 1 U of
Endo-IV and 20 pmol of viral fluorescent probes was used to test a
series of samples of different concentrations. The fluorescent intensity
was monitored at 42 °C every 20 s for 600 s by Applied Biosystems
ViiA7 instruments (Applied Biosystems, Switzerland).
Study Approval. No ethical approval for this study was required.
Patients gave general consent upon admission to the University
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